In contrast, in breast cancer cells, silencing USP13 can facilitate AKT phosphorylation by downregulating PTEN level, accompanied by tumor cell proliferation and glycolysis (Zhang et al., 2013). This evidence concerns the gene PTEN and breast carcinoma.